Reversible Restrictive Cardiomyopathy Due to Light-Chain Deposition Disease - Mayo Clinic Proceedings
Light Chain Deposition Disease | SpringerLink
Light-Chain (AL) Amyloidosis: Diagnosis and Treatment | American Society of Nephrology
A study from The Mayo Clinic evaluated long-term outcomes of kidney transplantation in patients with immunoglobulin light chain amyloidosis - Kidney International
CSF Kappa Free Light Chains: Cutoff Validation for Diagnosing Multiple Sclerosis - Mayo Clinic Proceedings
Evidence for Transition From Light Chain Deposition Disease by Immunofluorescence-Only to Classic Light Chain Deposition Disease - Kidney International Reports
Examples of abnormal kappa/lambda free light chain (κ/λ FLC) ratios in... | Download Table
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
The characteristics of patients with kidney light chain deposition disease concurrent with light chain amyloidosis - Kidney International
Utility of the Serum Free Light Chain Assay in the Diagnosis of Light Chain Amyloidosis in Patients With Heart Failure - Mayo Clinic Proceedings
The use of immunoglobulin light chain assays in the diagnosis of paraprotein-related kidney disease - Kidney International
Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement | Blood Cancer Journal
Absolute Risk of Progression of MGUS to Myeloma or Related Disorders... | Download Table
Cancers | Free Full-Text | Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All | HTML
AL Amyloidosis for the Cardiologist and Oncologist: Epidemiology, Diagnosis, and Management - ScienceDirect
Serum Polyclonal Immunoglobulin Free Light Chain Levels Predict Mortality in People With Chronic Kidney Disease - Mayo Clinic Proceedings
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
JCM | Free Full-Text | The Clone Wars: Diagnosing and Treating Dysproteinemic Kidney Disease in the Modern Era | HTML
Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance | NEJM
Update on treatment of light chain amyloidosis | Haematologica
The Heavy Chain Diseases: Clinical and Pathologic Features
The biology of immunoglobulin free light chains and kidney injury - Kidney International
